References
- Doyle LW. Victorian Infant Collaborative Study Group. Outcome at 5 years of age of children 23 to 27 weeks’ gestation: refining the prognosis. Pediatrics 108, 134–141 (2001).
- Doyle LW, Casalaz D; Victorian Infant Collaborative Study Group. Outcome at 14 years of extremely low birthweight infants: a regional study. Arch. Dis. Child. Fetal Neonatal Ed. 85, F159–F164 (2001).
- Liggins GC. Premature delivery of foetal lambs infused with glucocorticoids. J. Endocrinol. 45, 515–523 (1969).
- Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 50, 515–525 (1972).
- Crowley P, Chalmers I, Kierse MJ. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. BJOG 97, 11–25 (1990).
- NIH Consensus Development Panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 273, 413–418 (1995).
- ACOG Committee Opinion. Antenatal corticosteroid therapy for fetal maturation. Int. J. Gynaecol. Obstet. 48, 340–342 (1995).
- Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane. Database Syst. Rev. Issue 3, CD004454 (2006).
- Onland W, de Laat MW, Mol BW et al. Effects of antenatal corticosteroids given prior to 26 weeks’ gestation: a systematic review of randomized controlled trials. Am. J. Perinatol. 28, 33–44 (2011).
- Hayes EJ, Paul DA, Stahl GE et al. Effect of antenatal corticosteroids on survival for neonates born at 23 weeks of gestation. Obstet. Gynecol. 111, 921–926 (2008).
- Mori R, Kusuda S, Fujimura M. Antenatal corticosteroids promote survival of extremely preterm infants born at 22–23 weeks of gestation. J. Pediatr. 159, 110–114, e1 (2011).
- Abbasi S, Oxford C, Gerdes J et al. Antenatal corticosteroids prior to 24 weeks’ gestation and neonatal outcome of extremely low birth weight infants. Am. J. Perinatol. 27, 61–66 (2010).
- Schlapbach LJ, Adams M, Proietti E et al. Outcome at two years of age in a Swiss national cohort of extremely preterm infants born between 2000 and 2008. BMC Pediatr. 12, 198 (2012).
- Carlo WA, McDonald SA, Fanaroff AA et al. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22–25 weeks gestation. JAMA 306, 2348–2358 (2011).
- Raju TN. The problem of late-preterm births. A workshop summary. Pediatr. Res. 60, 775–776 (2006).
- Ramchandrappa A, Jain L. Health issues of late preterm infant. Pediatr. Clin. N. Am. 56, 565–577 (2009).
- Wang ML, Dorer DJ, Fleming MP et al. Clinical outcomes of near-term infants. Pediatrics 114, 372–376 (2004).
- McIntire DD, Leveno KJ. Neonatal mortality and morbidity rates in late preterm births compared with births at term. Obstet. Gynecol. 111, 35–41(2008).
- Teune MJ, Bakhuizen S, Bannerman C et al. A systematic review of severe morbidity in infants born late preterm. Am. J. Obstet. Gynecol. 205, 374 e1–e9 (2011).
- Jain L, Eaton DC. Physiology of fetal lung fluid clearance and the effect of labor. Semin. Perinatol. 30, 34–43 (2006).
- Venkatesh VC, Katzberg HD. Glucocorticoid regulation of epithelial sodium channel genes in human fetal lung. Am. J. Physiol. 273, L227–233 (1997).
- ACOG Committee Opinion No 475. Antenatal corticosteroid therapy for fetal maturation. Obstet. Gynecol. 117, 422–424 (2011).
- Gyamfi-Bannerman C, Gilbert S, Landon MB. Effect of antenatal corticosteroids on respiratory morbidity in singletons after late-preterm birth. Obstet Gynecol. 119, 555–559 (2012).
- Porto AN, Coutinho IC, Amorim MR. Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomized clinical trial. BMJ 342, 1696 (2011).
- Bowers SK, MacDonald HM, Shapiro ED. Prevention of iatrogenic neonatal respiratory distress syndrome: elective repeat cesarean section and spontaneous labor. Am. J. Obstet. Gynecol. 143, 186–189 (1982).
- Morrison JJ, Rennie JM, Milton PJ. Neonatal respiratory morbidity and mode of delivery at term: influence of timing of elective cesarean section. Br. J. Obstet. Gynaecol. 102, 101–106 (1995).
- Gerten KA, Coonrod DV, Bay RC et al. Cesarean delivery and respiratory distress syndrome: does labor make a difference? Am. J. Obstet. Gynecol. 193, 1061–1064 (2005).
- Roth-Kleiner M, Wagner BP, Bachmann D, Pfenninger J. Respiratory distress syndrome in near-term babies after cesarean section. Swiss. Med. Wkly 133, 283–288 (2003).
- Zanardo V, Simbi AK, Franzoi M et al. Neonatal respiratory morbidity risk and mode of delivery at term: influence of timing of elective cesarean delivery. Acta Paediatrica. 93, 643–647 (2004).
- American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 394, December 2007. Cesarean delivery on maternal request. Obstet. Gynecol. 110, 1501 (2007).
- Brown MJ, Olver RE, Ramsden CA et al. Effects of adrenaline and of spontaneous labour on the secretion and absorption of lung liquid in the fetal lamb. J. Physiol. 344,137–152 (1983).
- Avery ME, Gatewood OB, Brumley G. Transient tachypnea of newborn. Possible delayed resorption of fluid at birth. Am. J. Dis. Child. 111, 380–385 (1966).
- Sotiriadis A, Makrydimas G, Papatheodorou S et al. Corticosteroids for preventing neonatal respiratory morbidity after elective cesarean section at term. Cochrane. Database Syst. Rev. 7(4), CD006614 (2007).
- Stutchfield P, Whitaker R, Russell I et al. Antenatal Steroids for Term Elective cesarean Section (ASTECS) Research Team. Antenatal betamethasone and incidence of neonatal respiratory distress after elective cesarean section: pragmatic randomised trial. BMJ 33, 1662 (2005).
- Bernstein IM, Horbar JD, Badger GJ et al. Morbidity and mortality among very-lowbirthweight neonates with intrauterine growth restriction. Am. J. Obstet. Gynecol. 182, 198–206 (2000)
- Schaap AH, Wolf H, Bruinse HW et al. Effects of antenatal corticosteroid administration on mortality and long-term morbidity in early, preterm, growth-restricted infants. Obstet. Gynecol. 97, 954–956 (2001).
- Torrance HL, Derks JB, Scherion SA et al. Is antenatal steroid treatment effective in preterm IUGR fetuses? Acta Obstet. Gynecol. Scand. 88, 1068–1073 (2009).
- Miller SL, Chai M, Loose J et al. The effects of maternal betamethasone administration on the growth-restricted fetus. Endocrinology 148, 1288–1295 (2007).
- Vidaeff AC, Blackwell SC. Potential risks and benefits of antenatal corticosteroid therapy prior to preterm birth in pregnancies complicated by severe fetal growth restriction. Obstet. Gynecol. Clin. N. Am. 38, 205–214 (2011).
- Choi SJ, Song SE, Seo ES et al. The effect of single or multiple courses of antenatal corticosteroid therapy on neonatal respiratory distress syndrome in singleton versus twin pregnancies. Aust NZ J. Obstet. Gynaecol. 49, 173–179 (2009).
- Battista L, Winovitch KC, Rumney PJ et al. A case control comparison of the effectiveness of betamethasone to prevent neonatal morbidty and mortality in preterm twin and singleton pregnancies. Am. J. Perinatol. 25, 449–453 (2008).
- Ballabh P, Lo ES, Kumari J et al. Pharmacokinetics of betamethasone in twin and singleton pregnancy. Clin. Pharmacol. Ther. 71, 39–45 (2002).
- Gyamfi C, Mele L, Wapner RJ et al. The effect of plurality and obesity on betamethasone concentrations in women at risk for preterm delivery. Am. J. Obstet. Gynecol. 203, 219 e1–5 (2010).
- Blickstein I, Shinwell ES, Lusky A et al. Plurality-dependent risk of respiratory distress syndrome among very-low-birth-weight infants and antepartum corticosteroid treatment. Am. J. Obstet. Gynecol. 192, 360–364 (2005).
- McDonald SD, Han Z, Mulla S et al. Overweight and obesity in mothers and risk of preterm birth and low birth weight infants: systematic review and meta-analyses. BMJ 341, 3428 (2010).
- Hashima JN, Lai Y, Wapner RJ. The effect of body mass index on neonatal outcome in women receiving a single course of antenatal corticosteroids. Am. J. Obstet. Gynecol. 202, 263 e1–e5 (2010).
- Been JV, Degraeuwe PL, Kramer BW et al. Antenatal steroids and neonatal outcome after chorioamnionitis: a meta-analysis. BJOG 118, 113–122 (2011).
- Laughon M, Allred EN, Bose C et al. Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants. Pediatrics 123, 1124–1131 (2009).
- Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N. Engl. J. Med. 342, 1500–1507 (2000).
- DiGiulio DB, Romero R, Amogan HP et al. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture based investigation. PLoS ONE 3, e3056 (2008).
- Knox CL, Dando SJ, Nitsos I et al. The severity of chorioamnionitis in pregnant sheep is associated with in vivo variation of the surface-exposed multiple-banded antigen/gene of Ureaplasma parvum. Biol. Reprod. 83, 415–426 (2010).
- Kallapur SG, Kramer BW, Moss TJ et al. Maternal glucocorticoids increase endotoxin-induced lung inflammation in preterm lambs. Am. J. Physiol. Lung Cell Mol. Physiol. 284, L633–L642 (2003).
- Crowther A, McKinlay CJ, Middleton P et al. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane. Database Syst. Rev. 15(6), CD003935 (2011).
- Murphy KE, Willan AR, Hannah ME et al. Effect of Antenatal Corticosteroids on Fetal Growth and Gestational Age at Birth. Obstet Gynecol. 119, 917–923 (2012).
- Asztalos E, Murphy K, Hannah M et al. Multiple courses of Antenatal Corticosteroids for preterm birth study: 5 year outcomes (MACS-5). Am. J. Obgy. Gynecol. 208(1), S2–S3 (2013).
- Crowther CA, Doyle LW, Haslam RR et al. Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. N. Engl. J. Med. 357, 1179–1189 (2007)
- Wapner RJ, Sorokin Y, Mele L et al. Long-term outcomes after repeat doses of antenatal corticosteroids. N. Engl. J. Med. 357, 1190–1198 (2007).
- Norberg H, Stålnacke J, Nordenström A et al. Repeat Antenatal Steroid Exposure and later Blood Pressure, Arterial Stiffness, and Metabolic Profile. J. Pediatr. 163(3), 711–716 (2013).
- McLaughlin KJ, Crowther CA, Vigneswaran P et al. Who remains undelivered more than seven days after a single course of prenatal corticosteroids and gives birth at less than 34 weeks? Aust. NZ J. Obstet. Gynaecol. 42, 353–357 (2002).
- Garite TJ, Kurtzman J, Maurel K et al. Impact of a ‘rescue course’ of antenatal corticosteroids: a multicenter randomized placebo-controlled trial. Am. J. Obstet. Gynecol. 200, 248, e1–e9 (2009)
- Peltoniemi OM, Kari MA, Tammela O et al. Randomized trial of a single repeat dose of prenatal betamethasone treatment in imminent preterm birth. Pediatrics 119, 290–298 (2007).
- Vermillion ST, Bland ML, Soper DE. Effectiveness of a rescue dose of antenatal betamethasone after an initial single course. Am. J. Obstet. Gynecol. 185, 1086–1089 (2001).
- ACOG Committee Opinion. Antenatal corticosteroid therapy for fetal maturation. Obstet. Gynecol. 117, 422–424 (2011).
- Brownfoot FC, Crowther CA, Middleton P. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk for preterm birth. Cochrane. Database Syst. Rev. 4, CD006764 (2008).
- Lee BH, Stoll BJ, McDonald SA et al. Adverse neonatal outcomes associated with antenatal dexamethasone versus antenatal betamethasone. Pediatrics 117, 1503–1510 (2006).
- Elimian A, Garry D, Figueroa R et al. Antenatal betamethasone compared with dexamethasone (betacode trial): a randomized controlled trial. Obstet. Gynecol. 110, 26–30 (2007).
- NIH Consensus Development Panel. Antenatal corticosteroids revisited: repeat courses. Obstet. Gynecol. 98,144–150 (2000).
- Amorim MM, Santos LC, Faúndes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. Am. J. Obstet. Gynecol. 180, 1283–1288 (1999).
Website
- ClinicalTrials.gov Identifier: NCT01222247. http://clinicaltrials.gov/ct2/show/